Clinical Features of Patients With Overt or “Definitely Present” ATRA Syndrome
| UPN . | Age/Sex . | FAB . | WBC Count (×109/L) . | Therapy . | Outcome . | |
|---|---|---|---|---|---|---|
| . | . | . | Initial . | Peak . | . | . |
| . | . | . | . | (day of treatment) . | . | . |
| 07006 | 63/F | M3 | 0.5 | 5.9 (6) | ATRA discont./Dexamet. | CR |
| 24009 | 46/M | M3v | 54.2 | 101.0 (2) | ATRA discont./Dexamet. | CR |
| 24010 | 36/F | M3 | 7.2 | 18.2 (4) | ATRA discont./Dexamet. | CR |
| 35005 | 45/M | M3 | 11.6 | 25.8 (7) | ATRA discont./Dexamet. | CR |
| 55003 | 40/F | M3 | 0.6 | 1.6 (16) | ATRA discont./Dexamet. | CR |
| 24001 | 31/F | M3 | 1.5 | 5.1 (4) | ATRA discont./Dexamet. | Died |
| UPN . | Age/Sex . | FAB . | WBC Count (×109/L) . | Therapy . | Outcome . | |
|---|---|---|---|---|---|---|
| . | . | . | Initial . | Peak . | . | . |
| . | . | . | . | (day of treatment) . | . | . |
| 07006 | 63/F | M3 | 0.5 | 5.9 (6) | ATRA discont./Dexamet. | CR |
| 24009 | 46/M | M3v | 54.2 | 101.0 (2) | ATRA discont./Dexamet. | CR |
| 24010 | 36/F | M3 | 7.2 | 18.2 (4) | ATRA discont./Dexamet. | CR |
| 35005 | 45/M | M3 | 11.6 | 25.8 (7) | ATRA discont./Dexamet. | CR |
| 55003 | 40/F | M3 | 0.6 | 1.6 (16) | ATRA discont./Dexamet. | CR |
| 24001 | 31/F | M3 | 1.5 | 5.1 (4) | ATRA discont./Dexamet. | Died |
Abbreviation: discont./Dexamet., discontinuation/Dexamethasone.